Supplement S1 - Enteral Nutrition within 48 Hours of Admission Improves Clinical Outcomes of Acute Pancreatitis by Reducing Complications: A Meta-Analysis
Galunisertib (LY2157299), a selective ATP-mimetic inhibitor of TGF-β receptor I (TGF-βRI), is the only known TGF-β pathway inhibitor. In the present study, we investigated the effect of galunisertib o
This study intends to use blood and stool samples from patients with acute pancreatitis, using 16S rDNA, ELISA and other technologies to explore the relationship between changes in the intestinal flor